[1] JOHN T.-A. HSU. Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV[J]. FEBS Letters, 2004, 574 1-3: 116-120. DOI:
10.1016/j.febslet.2004.08.015[2] TING XIAO . Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis[J]. Phytomedicine, 2021, 91: Article 153704. DOI:
10.1016/j.phymed.2021.153704[3] YUNJEONG KIM. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.[J]. Journal of Virology, 2012, 86 21: 11754-11762. DOI:
10.1128/jvi.01348-12